investigated the molecular profiles and analyzed TMB in Chinese patients with gynecological cancers, including ovarian, cervical, and endometrial cancers, and found that the mutation of BRCA1 was associated with higher TMB in ovarian cancer patients52. This evidence concerns the gene BRCA1 and endometrial cancer.